Ventic, Ivy C.

HRN: 28-01-68  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/30/2025
CEFUROXIME 1.5GM (VIAL)
10/30/2025
11/06/2025
IV
1.5gm
Q8
Cholelithiasis
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: